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Abstract
Environmental factors, such as cigarette smoking or lung infections, may influence chronic obstructive pulmonary disease (COPD) pro-
gression by modifying the respiratory tract microbiome. However, whether the disease itself induces or maintains dysbiosis remains 
undefined. In this longitudinal study, we investigated the oropharyngeal microbiota composition and disease progression of mice (in 
cages of 5–10 mice per cage) before, during and up to 3 months after chronic cigarette smoke exposure or exposure to room air for 
6 months. Cigarette smoke exposure induced pulmonary emphysema measurable at the end of exposure for 6 months, as well as 
3 months following smoke exposure cessation. Using both classical culture methods and 16S rRNA sequencing, we observed that 
cigarette smoke exposure altered the relative composition of the oropharyngeal microbiota and reduced its diversity (P <0.001). More 
than 60 taxa were substantially reduced after 6 months of smoke exposure (P <0.001) However, oropharyngeal microbiota disordering 
was reversed 3 months after smoke exposure cessation and no significant difference was observed compared to age- matched control 
mice. The effects of lung infection with Streptococcus pneumoniae on established smoke- induced emphysema and on the oropharyn-
geal microbiota were also evaluated. Inoculation with S. pneumoniae induced lung damage and altered the microbiota composition 
for a longer time compared to control groups infected but not previously exposed to smoke (P=0.01). Our data demonstrate effects of 
cigarette smoke and pneumococcus infection leading to altered microbiota and emphysema development. The reversal of the disorder-
ing of the microbiota composition, but not lung damage, following smoke exposure cessation and after clearance of infection suggest 
that changes in lung structure are not sufficient to sustain a disordered microbiota in mice. Whether changes in the airway microbiota 
contribute to inducing emphysema requires further investigation.
DATA SUMMARY
The sequence reads from this work have been submitted to 
the European Nucleotide Archive under accession number 
PRJEB26965 (https://www. ebi. ac. uk/ ena/ browser/ view/ 
PRJEB26965).
INTRODUCTION
With one billion active smokers worldwide, cigarette smoking 
remains a leading risk of mortality and disease burden for 
cardiovascular disease, lung cancer and chronic obstructive 
pulmonary disease (COPD) [1]. The vast majority of COPD 
patients are specifically current cigarette smokers or former 
smokers [2, 3]. Genetic factors contribute to increasing the risk 
of developing COPD, as shown in association studies based on 
human genome sequencing and polymorphism analysis [4–8]. 
Indeed, the absolute risk of COPD is higher among genetically 
susceptible smokers [4]. Experimental mouse models have also 
emphasized the importance of genetic background in the extent 
of destruction of the lung parenchyma induced by cigarette smoke 
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exposure [9, 10]. Yet, neither smoking status nor genetic profiling 
alone nor combined can accurately predict whether an individual 
will develop COPD, suggesting additional contributing factors.
Recent studies point to the local microbiome in the airways and 
the lungs as potentially associated with disease progression and 
severity in lung diseases such as pulmonary fibrosis, cystic fibrosis, 
asthma and COPD [11–14]. As for the latter, a number of studies 
additionally confirmed significant host–microbiome interac-
tions in COPD revealing associations between the microbial 
composition, airway inflammation and exacerbations [15, 16]. 
Cigarette smoke is thought to influence the microbiome composi-
tion through immunomodulation [17–20], oxygen deprivation 
[21], increased bacterial biofilm formation [22, 23] and other 
mechanisms [24]. Analyses of bronchoalveolar lavage have shown 
smoking- induced differences in the mouth and oropharynx, but 
not in the lower respiratory tract microbiome of healthy human 
subjects [13, 25]. Longitudinal and functional studies are needed 
to ascertain relationships between altered microbiome, lung 
disease, genetics and environmental insults such as smoking [26].
It is known that airway infections are most often associated 
with disease exacerbations leading to a precipitous drop in lung 
function. Wang and colleagues identified Haemophilus and 
Moraxella as potential indicator genera in stable colonization and 
exacerbation related episodes, respectively [15]. Shared decreased 
activity of several innate immune defence mechanisms has been 
described for smoking individuals and COPD patients (see the 
paper by Sethi and Murphy [27] for more detailed information). 
The ‘Vicious Circle Hypothesis’ describes a spiralling process 
of ‘smokeborne’ airway infections that induce inflammatory 
reactions and impair innate lung defence mechanisms. This self- 
fuelling process favours bacterial persistence and proliferation, 
which increase susceptibility to further smokeborne infection 
events [27, 28], and can lead to severe and recurrent pneumonia. 
Recent reports have additionally stressed the importance of local-
ized infection foci within the lung parenchyma that may promote 
COPD progression [29, 30]. Streptococcus pneumoniae is a major 
causative pathogen of community- acquired pneumonia with 27 % 
of cases [31]. Smokers are at particularly higher risk of acquiring 
and developing S. pneumoniae- induced lung infection, as well as 
invasive pneumococcal disease, and they have worse outcome 
predictions as opposed to non- smoking patients [32]. However, 
little experimental data is available to link cigarette smoke expo-
sure with the respiratory tract microbiome and how infection may 
contribute to dysbiosis and progression of emphysema.
To investigate these interactions, we performed a longitudinal 
study where we characterized changes in the upper airway 
(oropharyngeal) microbiota over time in a chronic (6 month) 
cigarette- smoke- induced emphysema model in mice using 16S 
rRNA sequencing and bacterial cultures. Since bacterial infec-
tions are the most frequent cause for exacerbations in COPD, we 
further assessed the impact of S. pneumoniae infection on the 
microbiota composition in mice with established smoke- induced 
emphysema. By instillation of different S. pneumoniae strains in 
smoke- exposed and control air- exposed mice, we were able to 
detect dynamic changes of the oropharyngeal microbiota during 
the course of a self- resolving multifocal pneumonia. Overall, we 
determined whether infection altered the course of emphysema 
and whether emphysema contributed to the maintenance of a 
disordered microbiota.
METHODS
Experimental set-up and cigarette smoke exposure
Wild- type female C57BL/6J mice were purchased from Janvier 
Labs at the age of 4 weeks with a certified specific and opportun-
istic pathogen free (SOPF) status, and were left to acclimatize 
for 4 weeks. Upon delivery, mice were randomized in groups of 
5–10, ear marked and given a unique identification number in a 
mouse database (TierBase). From the start, groups of mice were 
randomly assigned to exposure regimen (cigarette smoke or room 
air) and to the different sample harvest protocol, infection group 
and timeline. Fig. 1(a) describes treatment and sampling at the 
cage level for control (cages C1–C10) and smoke- exposed (cages 
S1–S10) mice. Mice were housed in individually ventilated type 
II long or type III cages (blue line; Tecniplast), with a 12 h light/
dark cycle. Mice were fed ad libitum with autoclaved maintenance 
mouse chow (Kliba) and drank autoclaved acidified tap water. 
Impact Statement
Previous studies have suggested that a disordered 
lung microbiome is associated with chronic obstructive 
pulmonary disease (COPD) progression. Whether the 
disease itself or environmental causative factors, such 
as cigarette smoke or lung infection, are linked to a disor-
dered microbiome is not known. Therefore, experimental 
studies with a longitudinal design should be performed. 
Here, we performed multiple sampling of the oropharyn-
geal microbiota in mice at 3 month intervals before, 
during and after chronic exposure (6 months) to cigarette 
smoke, a model known to lead to emphysema in mice. 
Since bacterial infections are the most frequent cause 
for exacerbations in COPD, we additionally evaluated 
the impact of Streptococcus pneumoniae infection on the 
microbiota composition and disease progression in mice 
with established smoke- induced emphysema. Overall, 
we found that: (i) chronic cigarette smoke exposure 
causes emphysema and alters the composition of the 
oropharyngeal microbiota, as determined by 16S rRNA 
sequencing and by bacterial culture; (ii) lung infection 
with S. pneumoniae disrupts lung structure in air- and 
smoke- exposed mice, and induces a prolonged disor-
dering of the microbiota in the oropharynx in mice previ-
ously exposed to cigarette smoke compared to controls; 
(iii) the alterations in microbiota composition induced 
by cigarette smoke and by pneumococcal infection are 
reversed after smoke cessation and after resolution of 
pneumonia, respectively; (iv) an established emphysema 
after smoking cessation is not sufficient to maintain a 
disordered oropharyngeal microbiota.
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Fig. 1. Cigarette smoke induces irreversible emphysema. (a) Experimental scheme showing randomization of purchased female mice 
into cages of 5–10 mice. After a 4 week acclimation period, the experiment was initiated (time point 0). Groups of mice were exposed 
to cigarette smoke (cages S1, S2, S4, S5 and S6) or to room air (cages C1, C2, C4, C5, C6) for 6 months. Red boxes represent exposure 
to cigarette smoke. Note that smoke exposure was stopped at the 6 month time point for all groups. After 6 months of exposure, three 
sub- groups of control mice (C4, C5 and C6) and smoke- exposed mice (S4, S5 and S6) were further systematically randomized into 
four groups per exposure regimen and inoculated with 2×106 c.f.u. S. pneumoniae. The different strains were Sp1 (106.66 wild- type, 
serotype 6B), Sp2 (208.41 wild- type, serotype 7F), Sp3 (106.66 capsule mutant cps208.41, serotype 7F) and Sp4 (208.41 capsule mutant 
cps106.66, serotype 6B). The times of sampling of the microbiota with oropharyngeal swabs are shown. Analysis of lung structure (Hist) 
or BAL was performed in sub- groups of CTRL and SMK mice that were euthanized at 6 and 9 month time points. (b) Body weight was 
measured monthly. Data are shown as mean±sd (n=50 CTRL; n=55 SMK) and were analysed by two- way ANOVA (*** P<0.001, ** P <0.01, 
* P <0.05, ns (not significant). (c) Structural analysis of the lung parenchyma was performed at the indicated time points. Scatterplots 
show data for individual mice; median and interquartile range (box) are shown. Data were analysed by Mann–Whitney U test (** P <0.01).
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Only female mice were used to avoid potential animal welfare 
issues arising due to fighting in male mice and inability to isolate 
aggressive or injured animals in a long- term study.
3R4F reference cigarettes (University of Kentucky, Lexington, KY, 
USA) were stored at 4 °C and placed at room temperature into a 
closed container containing a glycerine/water mixture to maintain 
60 % relative humidity 2 days before use. Smoke was generated 
by a microprocessor- controlled Teague TE10z machine (Teague 
Enterprises) producing a mixture of mainstream (11 %) and side- 
stream (89 %) cigarette smoke and connected to whole- body 
exposure chambers to model second- hand exposure to cigarette 
smoke. Total suspended particulate density was maintained at 
100±6 mg m−3. On the first week of exposure, mice were gradu-
ally adapted by exposure for 30 min on the first day and then for 
additional 30 min increments every day. Every 90 min exposure 
was followed by a 60 min break where mice were exposed to room 
air. From the second week of exposure, mice were exposed for 
two sessions of 90 min separated by a break of 60 min, 5 days per 
week for 6 months.
Experimental set-up for the pneumococcus 
infection model
Groups of mice exposed to cigarette smoke (cages S4–S6) or air 
(cages C4–C6) for 6 months were randomly picked in a systematic 
manner and reassembled into corresponding subgroups (S7–S10 
or C7–C10) to be inoculated with one of four different strains of 
S. pneumoniae (Fig. 1a). Sp1 and Sp2 are clinical isolates 106.66 
(serotype 6B) and 208.41 (serotype 7F), respectively. Sp3 and Sp4 
are capsule switch mutants of these strains 106.66cps208.41 (7F) 
and 208.41cps106.66 (6B), respectively [33, 34]. For inoculation, 
mice were anesthetized with ketamine and xylazine (100mg/kg 
and 10mg/kg, respectively), and intranasally inoculated by pipet-
ting 20 µl onto the nares. Bacterial inoculum was determined as 
2×106 c.f.u. per mouse, a dose that we have previously shown to 
induce a multifocal self- resolving pneumonia and a prolonged 
colonization of the nasopharynx in C57BL/6 mice exposed to 
cigarette smoke [35].
Collection of oropharyngeal swabs
The oropharyngeal microbiota was sampled using ultrafine 
sterile flock swabs (HydraFlock, 25–3318 h; Puritan). Mice 
were anesthetized with isoflurane inhalation (4%) and 
handled in a biosafety cabinet. Swabs were orally inserted 
and gently rubbed on all sides of the pharynx. Each mouse 
was sampled twice: the tip of the first swab was cut into 
a molecular- grade sterile 2 ml tube and stored at −70 °C 
until DNA extraction was carried out; the tip of the second 
swab was used to inoculate two blood agar plates and two 
Columbia plates. To monitor for contamination, multiple 
control swabs were also processed for DNA extraction and 
bacterial culture at each throat swab collection.
Bacterial culture
Duplicate blood and Columbia agar plates were incubated at 
37 °C under aerobic or anaerobic conditions using accredited 
techniques (MicroBioS). Bacterial species were identified 
based on morphology and the abundance of each bacterial 
species was determined by colony counting. Control swabs 
were all negative.
Lung processing and analysis of lung structure
Stereological analysis of the lungs was performed as 
we reported previously and according to the American 
Thoracic Society/European Respiratory Society guidelines 
[36, 37]. Mice were euthanized with carbon dioxide and 
lungs were inflated at a constant pressure of 20 cm H2O 
with a buffered fixative solution (1.5 % paraformaldehyde, 
1.5 % glutaraldehyde, 0.15 M HEPES, pH 7.35) through a 
tracheal cannula. The trachea was ligated, and lungs were 
dissected and stored in fixative for at least 24 h. Total lung 
volume was determined by the water displacement method. 
Lungs were embedded in 2.5 % agar and sliced transversally. 
Systematic, uniform random sampling was used to pick five 
lung pieces representative of the whole organ and these 
pieces were embedded on a same plane in paraffin blocks. 
Lung sections (4 µm) were stained with haematoxylin and 
eosin. Approximately 50 micrographs at a final magnifica-
tion of ×200 were captured over the whole surface of the 
lung sections for each animal using a ColorView IIIu digital 
camera (Olympus Soft Imaging Solutions) on a Leica DM 
RB light microscope. Micrographs were equally and system-
atically placed in a meander using an automated motorized 
stage. Pictures were quantitatively analysed by using a test 
system of lines superimposed over the digital images via the 
STEPanizer [38]. Line counts intersecting septa were used 
to calculate the mean linear intercept (Lm).
Sample preparation for 16S rRNA amplicon 
sequencing
Sample processing, PCR amplification of the 16S rRNA 
and paired- end 2×250 bp sequencing (Reagent Kit v2) was 
performed as recently described and outlined in the Supple-
mentary Material [39]. The concentrations of samples were 
measured using the DNA 7500 kit with an Agilent 2100 
Bioanalyzer (Agilent Technologies). Resulting sequencing 
reads were analysed using the dada2 package version 1.5.0 
and workflow in R version 3.1.2. as described elsewhere and 
also reported in the Supplementary Material [40]. Statistical 
analysis not related to sequencing data was performed using 
Prism 8.0 (GraphPad). The test used and the number of 
animals/replicates are indicated in corresponding figure 
legends. P <0.05 was considered statistically significant.
RESULTS
Cigarette smoke causes irreversible emphysema 
and temporarily impairs body weight gain
Groups of SOPF C57BL/6JRj female mice were purchased at 
approximately 4 weeks of age and randomized in two groups 
(in cages of 5–10 mice per cage). After 1 month of acclima-
tization, mice were exposed to cigarette smoke (SMK, S) or 
room air (CTRL, C) for 6 months. After 6 months of exposure, 
subgroups of mice (C4, C5, C6, S4, S5 and S6) were further 
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randomized and inoculated with S. pneumoniae, while others 
were not inoculated (C1, C2, S1 and S2). All subgroups of mice 
(inoculated or not) were exposed to room air for 3 months to 
reach the 9 month time point (Fig. 1a). Exposure to cigarette 
smoke significantly impaired body weight gain, which was 
partly normalized following cessation of smoke exposure 
(Fig. 1b). Subsets of mice were euthanized 6 and 9 months 
after exposure initiation to evaluate pulmonary emphysema 
by measuring the Lm. In groups of mice not inoculated with S. 
pneumoniae, the Lm was higher in the SMK group compared 
to the CTRL group after 6 months of exposure, and remained 
significantly higher in the SMK group compared to the CTRL 
group until the final end point, 3 months after smoke cessa-
tion (Fig. 1c). Thus, our data indicate that chronic smoke 
exposure (6 months) induces emphysematous changes in the 
lung structure that are not reversible.
Cigarette smoke induces oropharyngeal 
disordering measured by 16S rRNA sequencing
For the subgroups of non- inoculated mice, the oropharynx 
was sampled before smoke exposure and at 3 month inter-
vals up to 3 months after the end of exposure (Fig.  1a, 
animals from cages C1–C2 and S1–S2). Analysing the 
bacterial density after 16S rRNA amplification revealed no 
significant differences in smoke- exposed mice as compared 
to control animals (Fig. S1, available with the online version 
of this article). We then evaluated the changes in the upper 
airway microbiota of these mice over time using 16S rRNA 
sequencing reads. Alpha- diversity analysis showed that 
smoke exposure for 6 months significantly reduced rich-
ness and Shannon’s diversity index, reflecting the number 
and relative abundance of species identified, respectively 
(Fig. 2a, b). No significant differences in alpha diversity 
were visible at the 9 month time point (Fig. 2a, b), indi-
cating that some aspects of disordering can be reversed 
following cessation of cigarette smoke exposure. Of note, 
alpha- diversity measurements were significantly different 
between the groups at the onset (0 month time point). 
This heterogeneity is likely due to pooling animals from 
various breeding cages at the vendors’ facility and further 
randomization upon arrival in our facility. However, using 
batch correction, we found that very few and rare sequence 
variants (SVs) (n=6) from three families were differentially 
abundant between the cages at time point zero (P value 
<0.001) (Fig. S2).
At the 3 month time point, we found no statistically 
relevant differences in alpha diversity between the groups, 
suggesting that initial differences noted at the basal time 
point were normalized after further co- housing and that 
cigarette smoke exposure for 3 months is insufficient to 
induce measurable changes in alpha diversity. In addi-
tion, differential analyses revealed only three SVs having 
a P value <0.001 for the log2 fold changes (see Fig. S3). 
To further illustrate the observed differences in the alpha- 
diversity analyses, we plotted the relative abundances of 
bacterial families at the 6 month time point (Fig. 2c, d). 
Relative abundances were strikingly altered by cigarette 
smoke exposure. Most prominently, Enterobacteriaceae and 
Lactobacillaceae were increased in the SMK compared to 
the CTRL group, while there was an almost complete loss 
of other normally abundant bacterial families (Fig. 2c, d). 
For the latter, differential analyses revealed 64 SVs being 
significantly decreased with a P value <0.001 for the log2 
fold changes between the CTRL and SMK groups (Fig. S4).
We further explored the beta- diversity indices of the 
oropharyngeal microbiota. Principal component analysis 
(PCoA) based on weighted Ružička distance matrix (DM) 
(abundance- based) showed that the samples clustered more 
strongly with the time points rather than exposure (Fig. 3a). 
A closer observation at each time point reveals that SMK 
and CTRL groups have minimal overlap with each other 
at the 0 and 6 month time points (Fig. 3a). Heterogeneity 
within groups measured by beta- dispersion analysis 
displayed as distances to centroid revealed a significantly 
reduced dispersion index after 6 months of smoke exposure 
(Fig. 3b). Beta- diversity analysis based on binary (presence 
or absence of SV) DM revealed more profound differences 
at the 6 month time point between SMK and CTRL groups 
(Fig. 3c). As in the weighed analysis, binary analysis also 
revealed a general clustering at each time point indepen-
dently of smoke exposure, with the notable exception of the 
SMK 6 month time point, which clustered more closely with 
SMK 3 month (Fig. 3c). At the 9 month time point, the SMK 
group samples overlapped in part with the SMK groups 
at 3 and 6 months and in part with CTRL groups at 6 and 
9 months, suggesting gradual reversal of changes induced 
by cigarette smoke exposure (Fig. 3c). In line, differential 
analyses of SVs only revealed two SVs being differentially 
abundant at the 9 month time point (P value <0.001) (see 
Fig. S5). In the binary analysis, distances to the centroids 
were not statistically different between SMK and CTRL 
groups (Fig. 3d). Taken together, these findings indicate 
that chronic exposure to second- hand cigarette smoke 
in mice alters the airway microbiota as best shown at the 
6 month time point using the binary Bray–Curtis PCoA.
Upper airway bacterial cultures are equally altered 
by cigarette smoke
We also evaluated longitudinal changes in the upper airway 
microbiota using standard culture techniques in aerobic 
and anaerobic conditions. The main motivation for the dual 
analysis was to broadly determine the culturable part of the 
microbiota, since sequencing techniques are not suitable to 
do so. The bacterial culture techniques revealed the presence 
of five major types of bacteria, Lactobacillus, Enterococcus, 
Staphylococcus, Enterobacter and Escherichia coli, which 
were also identified in the sequencing data (Fig.  4a, b). 
Changes in absolute counts but also in relative abundance 
of cultured bacteria were observed over time (Fig. 4a, b). 
Beta- diversity analysis based on weighted DM of absolute 
counts of bacteria showed effects of smoke exposure after 
6 months. In contrast, no differences were detected at the 
9 month time point, when SMK mice were not further 
exposed to cigarette smoke for 3 months (Fig. 4c). When 
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relative abundances rather than absolute counts were used 
for analysis, differences between exposure groups were 
noted at 9 months but not at 3 and 6 months after the start 
of exposure (Fig.  4d). However, beta- diversity analyses 
generally grouped the samples according to the time points 
within both analyses (Fig. 4c, d). Finally, weighted DM from 
the culture and the 16S rRNA sequencing microbiota data 
were compared and correlation analyses were performed 
(Fig. 4e, f). Both analyses of cultures using either absolute 
counts or relative abundance demonstrated significant 
correlations with the sequencing data (both with P <0.001) 
and r=0.36 and r=0.33, respectively. Taken together, these 
findings indicate that the results of sequencing and culture 
data inform differently on the altered microbiota, yet both 
approaches also clearly demonstrate similarities and that 
cigarette smoke exposure significantly modifies the micro-
biota of the upper airways.
Fig. 2. Dynamic changes in oropharyngeal microbiota alpha diversity induced by cigarette smoke. (a) Richness and (b) Shannon’s 
diversity index are shown for CTRL and SMK mice at the indicated time points (see Fig. 1a). Box- plots indicate median and interquartile 
range with mean indicated by + and with outliers shown. Data are from 8 to 10 mice per group sampled longitudinally and were analysed 
by two- way ANOVA (*** P <0.001, ** P <0.01, * P <0.05). (c, d) Bacterial genera identified by 16S rRNA sequencing at the 6 month time point 
are indicated for individual control (CTRL) (c) and smoke- exposed mice (SMK) (d). $ Bacteroidales includes all families of the order except 
Bacteroidaceae, which are shown separately.
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Fig. 3. Dynamic changes in oropharyngeal microbiota beta diversity induced by cigarette smoke. (a, b) Weighted Bray–Curtis- based 
PCoA (a) and corresponding beta- dispersion analysis (b) of the microbial composition at indicated time points for SMK and CTRL groups 
(Fig. 1a). (c, d) Binary Bray–Curtis- based PCoA (c) and beta- dispersion analysis (d). In PCoA (a, c), symbol shapes indicate time points 
(TP) (squares, 0; circles, 3; triangles, 6; asterisks, 9 months) with CTRL and SMK group- specific colours described in the key. The 1.0 
sd data ellipses are plotted for each group. Excluding the samples for TP=0, PERMANOVA P values were P=0.004 (time point), P=0.2 
(smoking status) and P=0.5 (smoking status:TP) for data using weighted Bray–Curtis- based PCoA (a). Excluding the samples for TP=0, 
PERMANOVA P values were P=0.001 (time point), P=0.003 (smoking status) and P=0.02 (smoking status:TP) for data using binary Bray–
Curtis- based PCoA (a). (b, d) Distances to centroid determined by beta- dispersion analysis are indicated as box- plots with median, 
interquartile range and outliers shown. Data are from 8 to 10 mice per group sampled longitudinally. The beta- dispersion data were 
analysed by Mann–Whitney U test (** P <0.01).
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Fig. 4. Dynamic changes in oropharyngeal bacterial cultures induced by cigarette smoke. (a, b) Mean absolute numbers of c.f.u. (a) and 
mean relative abundance (b) of bacterial species cultured from the throat swabs of mice exposed to air (CTRL) or cigarette smoke (SMK) 
at the indicated time points. (c, d) Bray–Curtis- based PCoA of c.f.u. values (c) and relative abundance (d) of bacterial species are shown 
for SMK and CTRL mice at the indicated time points. Symbol shapes indicate time points (squares, 0; circles, 3; triangles, 6; asterisks, 
9) with CTRL and SMK group- specific colours described in the key. Data are from 8 to 10 mice per group sampled longitudinally. (e, f) 
Regression analysis between the DMs of the microbiota sequencing data and (e) the bacterial c.f.u. values and (f) the relative abundance 
of bacterial species.
9
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S. pneumoniae infection further increases chronic 
emphysematous lung injury induced by cigarette 
smoke
Additional groups of mice that were similarly exposed 
to cigarette smoke for 6 months were inoculated intrana-
sally with S. pneumoniae, a pathogen frequently isolated 
in patients with progressing COPD (Fig. 1a). No further 
smoke exposure was applied following infection. Lm 
measured at 90 days post- infection showed a statisti-
cally significant increase in emphysematous changes in 
S. pneumoniae- inoculated SMK mice compared to inocu-
lated CTRL mice (Fig. 5a, P=0.01). Importantly, the Lm 
was increased in infected CTRL mice compared to unin-
fected CTRL mice at the equivalent 9 month time point 
(P=0.0045), and the Lm was further increased in infected 
SMK mice compared to uninfected CTRL mice (P <0.001) 
(Fig. 5a). While we did not find a statistically significant 
difference between the Lm of SMK infected compared 
to SMK uninfected groups, the overall data suggest that 
both cigarette smoke exposure and bacterial infection can 
contribute to disrupt lung structure. Of note, mice were 
inoculated with either of two different strains 106.66 (Sp1) 
and 208.41 (Sp2) of S. pneumoniae (serotype 6B and 7F, 
respectively) or with one of the two capsule switch mutants 
(Sp3, Sp4) [34], where the capsule gene defines the sero-
type (Fig. 5b). The data suggest strain- specific effects on 
emphysema development with more noticeable effects for 
the 106.66 strain (Sp1) and its capsule mutant (Sp3) [33]. 
However, direct comparisons between strains and with 
respective mutants were not feasible due to low statistical 
power.
Infection-induced changes in upper airway 
microbiota are sustained by prior cigarette smoke 
exposure and emphysema
Oropharyngeal swabs were collected after 6 month of expo-
sure and before inoculation (0 days post- infection) and then 
at multiple time points after inoculation with S. pneumoniae 
(Fig. 1a). The extent of the disordering induced by infection 
with pneumococcus in SMK and CTRL mice was analysed 
at the indicated time points post- infection. In both SMK 
and CTRL mice, infection caused a decrease in diversity at 
14 days post- infection (Fig. 6a–c). Importantly, diversity 
indices were significantly reduced at 30 days post- infection 
in the SMK group compared to the CTRL group. At 60 and 
90 days after infection, richness and Shannon’s diversity 
index values were increased within each group, indicating 
that changes due to infection were reversible. Analysis of 
the relative abundances of bacterial families revealed an 
increase of Lactobacillaceae for both groups at 14 days post- 
infection and only in the SMK group at 30 days (Fig. 6c). 
Hierarchical cluster analyses based on the relative abun-
dances of SVs also suggested a distinct clustering for the 
three sample groups (14 day CTRL, 14 day SMK and 30 day 
SMK) from the other groups (Fig. 6d). Taken together, our 
data indicate that chronic cigarette smoke exposure induced 
both pulmonary emphysema and a disordered microbiota 
in the upper airways. In addition, smoke exposure cessa-
tion lead to a normalization of the microbiota, but defects 
in lung structure persisted with age even after cessation 
(Fig. 7a). Thus, an emphysematous lung is not sufficient 
to maintain a disordered microbiota. Furthermore, our 
data show that pneumococcal lung infection exacerbated 
emphysematous changes induced by cigarette smoke, and 
that smoke exposure and infection synergized to sustain 
microbiota disordering (Fig. 7b).
Fig. 5. Emphysema in mice exposed to cigarette smoke and 
pneumococcal infection. Structural analysis of the lung parenchyma 
was performed at the 9 month time point. (a) Lm of CTRL and SMK 
groups infected with S. pneumoniae; data of the 9 month time point 
of the first experiment are shown for reference (mock). (b) Lm for 
individual subgroups infected with strains Sp1 (106.66 wild- type, 
serotype 6B), Sp2 (208.41 wild- type, serotype 7F), Sp3 (106.66 capsule 
mutant cps208.41, serotype 7F) and Sp4 (208.41 capsule mutant 
cps106.66, serotype 6B). Scatterplots show data for individual mice; 
median, interquartile range (box) and mean (+) are shown. Data were 
analysed by one- way ANOVA. ns denotes for non- significant
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Fig. 6. Dynamic changes in oropharyngeal microbiota induced by cigarette smoke and S. pneumoniae. (a) Richness, (b) Shannon’s diversity 
index and (c) mean relative abundance of bacterial genera are shown for CTRL and SMK groups at the indicated time points relative to 
pneumococcal infection (see the experimental scheme in Fig. 1a). (a, b) Box- plots indicate median and interquartile range with mean 
indicated as + and with outliers shown. (c) Abundance of bacterial genera identified by 16S rRNA sequencing at each time point show 
the mean relative abundance for CTRL (C) and SMK (S) at the indicated time points. Data were analysed by one- way ANOVA (** P <0.01). 
(d) Hierarchical clustering analysis of the microbial composition. The mean of the relative abundances of the SVs per sample group 
has been calculated and the DM created. The dendrogram is based on the DM of all SVs, while the heatmap only visualizes SVs with at 
least 1 % relative abundance in the respective sample group. All data are from 20 to 24 mice per group sampled longitudinally. SVs are 
named at the genus level. Staph., Parabact., and Enteract indicate Staphylococcus, Parabacteroides and Enteractinococcus, respectively. 
$Bacteroidales includes all families of the order except Bacteroidaceae, which is shown separately.
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DISCUSSION
Several cross- sectional studies have shown that a disordered 
lung microbiome is associated with COPD [13, 41]. However, 
only a few reports included an experimental design that would 
reveal longitudinal relationships between a changing micro-
biome and disease phenotypes [15, 42]. We acknowledge 
that the human respiratory tract microbiome is likely more 
varied and distinct from the microbial communities of labora-
tory mice. Yet, mouse models are relevant, controlled tools 
to investigate temporal changes in the microbiome during 
disease development. The oropharynx – rather than the lower 
airways – was preferred here as it allowed multiple, longitu-
dinal sampling of the same mice at multiple time points in 
the study. Cigarette smoke exposure is also a relevant model 
inducing chronic lung disease as it is a common causal factor 
in both humans and mice. Low- biomass microbiome studies 
specifically require multiple procedural quality controls to 
rule out contamination [43–45]. In our case, bacterial DNA 
content of negative control swabs was below the predefined 
cut- off for sequencing for all specimens. In addition, no colo-
nies were produced from any negative control oropharyngeal 
swab using standard culture techniques under aerobic and 
anaerobic conditions. There were also some significant corre-
lations between the different datasets (16S rRNA and culture), 
further indicating that 16S rRNA sequencing data truly were 
originating from culturable bacteria and not from reagents 
used in DNA isolation and library preparation, which can 
contain contaminating bacterial DNA [44]. The chosen model 
and methods provide experimental evidence that cigarette 
smoke exposure and pneumococcal lung infection induce 
profound but reversible disordering of the oropharyngeal 
microbiota. To some extent, our conclusions may be extrapo-
lated to better understand human respiratory diseases.
In this study, we first analysed the effects of cigarette smoke 
exposure on the composition of the oropharyngeal micro-
biota and on the development of chronic pulmonary disease. 
The oropharyngeal microbiota composition has been found to 
correlate better with the lower airway microbiota as compared 
to other sites such as the nasopharynx [46, 47]. Analysis of 
the oropharyngeal microbiota using 16S rRNA sequencing 
revealed major changes induced by cigarette smoke after 
6 months of exposure, but not after only 3 months. Compared 
to the control mice, the abundance of Lactobacillus spp. was 
increased and other taxa were significantly decreased in 
the smoke- exposed mice after 6 months. An earlier study 
investigated the correlation between smoking and salivary 
microbe levels in 780 human subjects [48]. Though salivary 
and oropharyngeal samples are not directly comparable, 
smoking was strongly associated with higher Lactobacillus 
counts in saliva. Increased proportions of high Lactoba-
cillus counts were also reported in the saliva of smokers in 
a study including an unmedicated adult population of 462 
non- smokers and 180 smokers [49]. In addition to increased 
Lactobacillus spp., we also observed a decrease in the values of 
the alpha diversity after 6 months of cigarette smoke exposure. 
In a recent study, bronchial wash samples from adults with 
COPD (n=18), smokers with no airway disease (n=8) and 
healthy individuals (n=11) were analysed by extended- culture 
and culture- independent Illumina MiSeq sequencing [50]. As 
in our study, microbial community composition of patients 
with COPD was significantly different from that found in 
Fig. 7. Graphical summary of the combined effects of cigarette smoke and S. pneumoniae infection on lung structure and the 
oropharyngeal microbiota. (a) Chronic cigarette smoke exposure induces irreversible emphysematous changes in lung structure and 
reversible changes on microbiota composition in the oropharynx. Thus, an established pulmonary emphysema is not sufficient to 
maintain dysbiosis in the upper respiratory tract. (b) Pneumococcal infection of an established emphysematous lung induces disease 
exacerbation with long- term consequences on lung structure and a sustained, but reversible, alteration of the oropharyngeal microbiota. 
Thus, while infection causes structural lung damage, it remains to be established whether a disordered airway microbiota is necessary 
or sufficient for the development and/or progression of emphysema.
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smokers and non- smokers, including decreased alpha diver-
sity, suggesting that changes in microbiological status are a 
component of the pathogenesis.
In our study, we observed that the upper airway bacterial 
communities of SOPF mice from the same unit of a single 
provider can be heterogeneous, as illustrated by high alpha 
diversity even after 1 month of co- housing before the first 
sampling at day 0. Similarly, no core lung microbiota was 
found at day 0 in a study comparing lung, tongue and caecal 
bacteria in 40 healthy, genetically identical, 10- week- old 
mice, using 16S rRNA quantification and sequencing 
[44]. Furthermore, increased duration of co- housing then 
led to a conversion of murine lung bacteria, which we 
observed also in this study of the oropharynx microbiota 
with greater similarity between groups at the 9 month time 
point. Duration of smoke exposure also seems to be critical 
to observe changes in the microbiota composition. In an 
experimental mouse model, cigarette smoke exposure for 
1 week did not alter the nasal microbiota composition [51]. 
Similarly, we found that the oropharynx microbiota did not 
reveal disordered microbial communities after 3 months, 
but only after 6 months of smoke exposure. These findings 
indicate that long- term smoke exposure in combination 
with emphysema development is likely required to induce 
differences in the microbiota composition. Importantly, we 
found that cessation of smoke exposure for 3 months led 
to a reversal of the changes, indicating that normalization 
of the microbiota may be an additional beneficial effect of 
smoking cessation. Perhaps as a limitation, we only inves-
tigated female mice though the sex is potentially important 
in lung microbiome research [52].
It is difficult to disentangle the direct effects of long- term 
smoke exposure on microbiome disordering from those 
mediated by inflammation. A case for the effects of host 
response on the microbiome is supported by experimental 
and epidemiological studies. Mice challenged with lipopoly-
saccharide (LPS)/elastase intranasally over 4 weeks develop 
a chronically inflamed and damaged lung, and a decrease in 
lung microbiota richness and diversity [53]. An increased 
representation of the genera Pseudomonas and Lactobacillus 
and a reduction in Prevotella were specifically reported. 
Although the sampling approach and mouse model in that 
study differed from ours, both studies showed decreased 
alpha- diversity values and increased Lactobacillus in 
association with the development of emphysema. Further-
more, smokers without overt lung disease appear to have 
an unchanged lung microbiota composition as compared 
to non- smokers [25, 50]. It is tempting to speculate that 
smoke- induced COPD in humans and emphysema in mice 
require a prior change in the microbiota, but this remains 
to be experimentally proven.
Pulmonary infections are important factors in disease exac-
erbations in advanced COPD. Yet, it is unclear whether such 
infections contribute further to chronic structural defects 
and whether they have consequences on the local micro-
biome. The additive effects of cigarette smoke exposure and 
of Streptococcus infection on emphysema severity, micro-
biome alteration and colonization were evaluated in mice 
exposed for 6 months and inoculated with four different 
pneumococcal strains. We chose serotype 6B and 7F strains, 
which have been shown to have different pneumococcal 
capsule thickness due to the difference in the efficiency for 
the precursor usage for capsule synthesis [34]. We used a 
relatively high infectious dose that we previously established 
was non- lethal but yet sufficient to cause pneumonia and a 
prolonged colonization in mice exposed to cigarette smoke 
[35]. We found that lung infection worsens the emphysema 
as measured 90 days after infection and it may also affect 
lung structure in control mice. In addition, we found that 
pneumococcal infections induce a more durable dysbiosis 
in mice previously exposed to smoke. However, these effects 
appear to be transient and emphysema did not promote 
a long- term establishment of a modified microbiome. We 
were not able to conclude on pneumococcal strain- specific 
differences in part because intra- group variation was higher 
than anticipated, which reduced the statistical power of the 
study. However, there was a tendency that the wild- type 
106.66 strain of the frequently isolated serotype 6B caused 
more severe diseases compared to the 208.41 invasive sero-
type 7F pneumococcal strain. In an earlier study, the ability 
of identical 6B and 7F wild- type strains and mutants to 
colonize the nasopharynx of outbred MF1 female mice was 
investigated [33]. At day 7, a disadvantage of a 7F capsule, 
but not a 6B capsule, in colonization was apparent. Our 
data suggest that the capsule type has less importance in 
enhancing smoke- induced emphysema as the two strains 
with the 106.66 backbone (Sp1 and Sp3) tended to have 
higher Lm values regardless of capsule type. Further work 
is required to investigate these findings. We previously 
examined the clearance of S. pneumoniae and Pseudomonas 
aeruginosa and associated immune responses in mice 
exposed to cigarette smoke or after smoking cessation [35]. 
We found that cigarette smoke induced a temporary and 
reversible increase in the clearance of lung pathogens. This 
is in line with this study, which suggests that the changes 
in the microbiota are reversible upon cessation of smoke 
exposure.
To conclude, we demonstrated a synergistic effect between 
cigarette smoke exposure, altered microbiota and pneu-
mococcal infection leading to persistent emphysematous 
changes in the lungs. While smoke- induced and infection- 
induced microbiota disordering were each reversible upon 
smoke exposure cessation and infection clearance, there 
was also an association that the structural changes of the 
lung were sustained and additively impacted by the two 
challenges. Whether dysbiosis is necessary and sufficient for 
emphysema development remains to be proven experimen-
tally and our data suggest that microbiota transfer studies 
are warranted.
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